{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:41:32Z","timestamp":1793353292852,"version":"4.5.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.pain.2004.05.010","type":"journal-article","created":{"date-parts":[[2004,7,7]],"date-time":"2004-07-07T20:34:31Z","timestamp":1089232471000},"page":"697-706","source":"Crossref","is-referenced-by-count":401,"title":["Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study"],"prefix":"10.1097","volume":"110","author":[{"given":"Michael C","family":"Rowbotham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeraindar","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia R","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-24-20210126","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1176\/ajp.152.12.1832a","article-title":"Venlafaxine for treatment of obsessive-compulsive disorder.","volume":"152","author":"Ananth","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R3-24-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/13651509809115370","article-title":"Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting.","volume":"2","author":"Arias","year":"1998","journal-title":"Int J Psychiatry Clin Prac"},{"key":"R5-24-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(98)00064-5","article-title":"A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.","volume":"76","author":"Atkinson","year":"1998","journal-title":"Pain"},{"key":"R4-24-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3959(99)00082-2","article-title":"Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.","volume":"83","author":"Atkinson","year":"1999","journal-title":"Pain"},{"key":"R6-24-20210126","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.","volume":"280","author":"Backonja","year":"1998","journal-title":"J Am Med Assoc"},{"key":"R7-24-20210126","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2125.1997.00591.x","article-title":"Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.","volume":"43","author":"Ball","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R8-24-20210126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"R9-24-20210126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.8.2.125","article-title":"The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population.","volume":"8","author":"Boulton","year":"1985","journal-title":"Diabetes Care"},{"key":"R10-24-20210126","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect.","volume":"310","author":"Cook","year":"1995","journal-title":"Br Med J"},{"key":"R11-24-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0278-5846(95)00292-8","article-title":"A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.","volume":"20","author":"Dierick","year":"1996","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R13-24-20210126","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0033-3182(98)71375-1","article-title":"An open clinical trial of venlafaxine treatment of fibromyalgia.","volume":"39","author":"Dwight","year":"1998","journal-title":"Psychosomatics"},{"key":"R14-24-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"R15-24-20210126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptive modulatory circuits.","volume":"14","author":"Fields","year":"1991","journal-title":"Ann Rev Neurosci"},{"key":"R16-24-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10401239709147806","article-title":"Sertraline in diabetic neuropathy: preliminary results.","volume":"9","author":"Goodnick","year":"1997","journal-title":"Ann Clin Psychiatry"},{"key":"R18-24-20210126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1056-8727(00)00060-X","article-title":"Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.","volume":"14","author":"Harati","year":"2000","journal-title":"J Diabet Complications"},{"key":"R19-24-20210126","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","article-title":"Evidence of the dual mechanisms of action of venlafaxine.","volume":"57","author":"Harvey","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R20-24-20210126","first-page":"85","article-title":"Diabetic neuropathy.","volume":"78-","author":"Horowitz","year":"1993","journal-title":"Clin Orthop"},{"key":"R21-24-20210126","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","article-title":"Measurement of pain.","volume":"2","author":"Huskisson","year":"1974","journal-title":"Lancet"},{"key":"R22-24-20210126","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199856040-00016","article-title":"Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.","volume":"56","author":"Jarvis","year":"1998","journal-title":"Drugs"},{"key":"R23-24-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pain.2003.08.010","article-title":"Is noradrenaline a significant factor in the analgesic effect of antidepressants?","volume":"106","author":"Jasmin","year":"2003","journal-title":"Pain"},{"key":"R24-24-20210126","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1345\/aph.18431","article-title":"Tricyclic antidepressant use in diabetic neuropathy.","volume":"33","author":"Joss","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R25-24-20210126","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1001\/jama.1992.03490240049035","article-title":"Antidepressant medications and the relative risk of suicide attempt and suicide.","volume":"268","author":"Kapur","year":"1992","journal-title":"J Am Med Assoc"},{"key":"R26-24-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(96)03223-X","article-title":"Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy.","volume":"68","author":"Lang","year":"1996","journal-title":"Pain"},{"key":"R27-24-20210126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3959(03)00168-4","article-title":"Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.","volume":"103","author":"Marchand","year":"2003","journal-title":"Pain"},{"key":"R28-24-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-3959(91)90157-S","article-title":"Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.","volume":"45","author":"Max","year":"1991","journal-title":"Pain"},{"key":"R29-24-20210126","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"key":"R31-24-20210126","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review.","volume":"311","author":"McQuay","year":"1995","journal-title":"Br Med J"},{"key":"R32-24-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A systematic review of antidepressants in neuropathic pain.","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"R33-24-20210126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.v61n0204","article-title":"Behnke K, for the Venlafaxine 631 Study Group. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder.","volume":"61","author":"Mehtonen","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R34-24-20210126","first-page":"169","article-title":"Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.","volume":"29","author":"Mendels","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"R35-24-20210126","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/0006-2952(86)90769-0","article-title":"Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.","volume":"35","author":"Muth","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"R36-24-20210126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00002826-199510000-00002","article-title":"Pharmacology of neuropathic pain.","volume":"18","author":"Ollat","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"R37-24-20210126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.","volume":"333","author":"Partanen","year":"1995","journal-title":"N Engl J Med"},{"key":"R38-24-20210126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1037\/h0021000","article-title":"Factors of psychopathology in interview, ward behavior, and self-report ratings of hospitalized depressives.","volume":"31","author":"Raskin","year":"1967","journal-title":"J Consult Psychol"},{"key":"R39-24-20210126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0091-3057(87)90548-X","article-title":"A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs.","volume":"26","author":"Sacerdote","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"R40-24-20210126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archinte.162.1.19","article-title":"The effect of antidepressant treatment on lower back pain: a meta-analysis.","volume":"162","author":"Salerno","year":"2002","journal-title":"Arch Intern Med"},{"key":"R41-24-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(99)00627-8","article-title":"The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms.","volume":"273","author":"Schreiber","year":"1999","journal-title":"Neurosci Lett"},{"key":"R44-24-20210126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"R45-24-20210126","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1212\/WNL.55.7.915","article-title":"Pharmacologic treatment of pain in polyneuropathy.","volume":"55","author":"Sindrup","year":"2000","journal-title":"Neurology"},{"key":"R43-24-20210126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","article-title":"The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.","volume":"42","author":"Sindrup","year":"1990","journal-title":"Pain"},{"key":"R42-24-20210126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/clpt.1992.183","article-title":"The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy.","volume":"52","author":"Sindrup","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R46-24-20210126","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"key":"R47-24-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/eujp.2001.0266","article-title":"Venlafaxine in neuropathic pain following treatment of breast cancer.","volume":"6","author":"Tasmuth","year":"2002","journal-title":"Eur J Pain"},{"key":"R48-24-20210126","first-page":"147","article-title":"Venlafaxine hydrochloride and chronic pain.","volume":"165","author":"Taylor","year":"1996","journal-title":"West J Med"},{"key":"R49-24-20210126","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4088\/JCP.v58n0904","article-title":"209 Study Group. Efficacy and tolerability of once-daily venlafaxine extended release (ER) in outpatients with major depression.","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R50-24-20210126","first-page":"51","article-title":"A double-blind, randomized, 12-week comparison study of the safety and efficacy of venlafaxine and fluoxetine in moderate to severe major depression in general practice.","volume":"3","author":"Tylee","year":"1997","journal-title":"Primary Care Psychiatry"},{"key":"R51-24-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3959(92)90128-X","article-title":"Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial.","volume":"48","author":"Watson","year":"1992","journal-title":"Pain"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200408000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:13:45Z","timestamp":1785784425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200408000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2004.05.010","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}